Drug class
Tetracyclic antidepressant; noradrenergic and specific serotonergic antidepressant (NaSSA)
Mechanism of action
The mechanism in major depressive disorder is not fully understood. Mirtazapine antagonises central presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, potentially increasing noradrenergic and serotonergic neurotransmission; it also antagonises 5-HT2, 5-HT3 and H1 receptors.
General use cases
- Treatment of major depressive disorder in adults; the exact contribution of noradrenergic and serotonergic actions to clinical response is not fully established
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
